Exact Sciences Corporation
EXASNASDAQHealthcare
$104.91
+$0.00(+0.00%)
Market Cap$20.0B
P/E Ratio—
52W High$104.98
52W Low$38.81
Exact Sciences Corporation（EXAS）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EXAS · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.21B) | ($1.03B) | ($0.20B) | ($0.62B) | ($0.60B) |
| Depreciation & Amort. | $0.22B | $0.21B | $0.21B | $0.20B | $0.18B |
| Stock-Based Comp. | $0.22B | $0.21B | $0.23B | $0.21B | $0.25B |
| Change in Working Capital | $0.12B | ($0.06B) | ($0.00B) | ($0.03B) | $0.11B |
| Net Cash from Operations | $0.49B | $0.21B | $0.16B | ($0.22B) | ($0.10B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.13B) | ($0.14B) | ($0.12B) | ($0.21B) | ($0.14B) |
| Purchases of Investments | ($0.20B) | ($0.47B) | ($0.16B) | ($0.17B) | ($1.16B) |
| Sales of Investments | $0.57B | $0.21B | $0.38B | $0.45B | $0.79B |
| Net Cash from Investing | $0.20B | ($0.44B) | $0.05B | $0.07B | ($1.08B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.25B) | $0.22B | $0.14B | $0.05B | ($0.02B) |
| Net Cash from Financing | ($0.34B) | $0.23B | $0.16B | $0.08B | $0.01B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.36B | $0.07B | $0.03B | ($0.44B) | ($0.24B) |
| FCF Margin %(computed) | 10.99% | 2.70% | 1.28% | -21.02% | -13.47% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Exact Sciences Corporation
关于Exact Sciences Corporation（EXAS）现金流量表
Exact Sciences Corporation 2025财年经营活动现金流$0.49B，自由现金流$0.36B（FCF利润率10.99%），资本支出($0.13B)。
常见问题
EXAS · 4 问Exact Sciences Corporation 2025财年自由现金流$0.36B，同比up378.6%。
EXAS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10